secwatch / observer
8-K filed October 3, 2024, 7:59 PM ET ticker ARMP CIK 0000921114
leadership confidence high sentiment neutral materiality 0.30

Armata Pharma VP Corporate Controller departs; receives base salary through Dec 2024

Armata Pharmaceuticals, Inc.

item 5.02item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Richard Rychlik

Vice President, Corporate Controller
ARMP · Armata Pharmaceuticals, Inc.
Effective
2024-09-30
Filed
October 3, 2024, 7:59 PM ET
On September 26, 2024, Armata Pharmaceuticals, Inc. (the “ Company ”) disclosed that it had reached an agreement with Richard Rychlik, the Company’s Vice President, Corporate Controller, pursuant to which Mr. Rychlik’s employment would conclude effective as of September 30, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Richard Rychlik departed as Vice President, Corporate Controller at Armata Pharmaceuticals, Inc..

Action
employment concluded
Role
Vice President, Corporate Controller
Exact text from the filing
On September 26, 2024, Armata Pharmaceuticals, Inc. (the “ Company ”) disclosed that it had reached an agreement with Richard Rychlik, the Company’s Vice President, Corporate Controller, pursuant to which Mr. Rychlik’s employment would conclude effective as of September 30, 2024.
View on SEC.gov

Armata Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR
accession 0001104659-24-105853
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.